DYNAVAX TECHNOLOGIES CORP - DVAX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$146.3M
QoQ value delta ($000)
-$1.587B
(-91.56%)
Implied price effect (QoQ)
+0.01%
Shares
Total shares
9,515,335
QoQ shares delta
-103,219,933
(-91.56%)
Total shares held by funds (by quarter)
Market chart (DVAX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 123,462 | 8,027,448 | 0.0% |
| TWO SIGMA ADVISERS, LP | 20,274 | 1,318,218 | 0.04% |
| Carmignac Gestion | 1,722 | 111,974 | 0.02% |
| AlphaQuest LLC | 384 | 24,991 | 0.02% |
| COMERICA BANK | 351 | 22,865 | 0.0% |
| CIBC Private Wealth Group LLC | 100 | 6,524 | 0.0% |
| Global Retirement Partners, LLC | 42 | 2,780 | 0.0% |
| GPS Wealth Strategies Group, LLC | 6 | 429 | 0.01% |
| Motiv8 Investments LLC | 2 | 100 | 0.0% |
| IFP Advisors, Inc | 0 | 6 | 0.0% |